12

Jun

2020

17:00

BST

Live Stream

Transcatheter Interventions Online | Day 3 – Recent trials & future technologies

  • Views:

    Views Icon 76
  • Likes:

    Heart Icon 2

Overview

The programme aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centres of excellence globally, interspersed with presentations and debate sessions.

CME Accreditation

This three-day programme has been accredited by the European Board for Accreditation in Cardiology (EBAC) for a total of 12 CME points, equating to 12 hours of learning (4 hours per day). Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website https://www.ama-assn.org/

Day 1 - Structural Heart Interventions

10th June 4-8pm CEST (10am – 2pm ET)

Watch on demand

Day 2: Complex & High Risk Indicated PCI

11th June 4-8pm CEST (10am – 2pm ET)

Watch on demand

Day 3: Updates on recent trials & future technologies

12th June 4-8pm CEST (10am – 2pm ET)

Watch on demand

Performed By:

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Moderated By:

Kendra J Grubb

Kendra J Grubb

David Hildick-Smith

David Hildick-Smith

Holger Thiele

Holger Thiele

This live stream is supported by:

Agenda

4 - 5.30pm: PART 3.1 - Trials - 90 minutes

Intro: Nicolas Van Mieghem
SESSION CHAIRS: Roxana Mehran, Holger Thiele
SESSION PANEL: Ajay Kirtane, Lars Sondergaard, Kendra Grubb, David Hildick-Smith


1. ISCHEMIA practical perspectives – 15 minutes – Ajay Kirtane
15 minutes discussion

2. Latest in pharmacology: acute and stable coronary syndromes – 15 minutes – Roxana Mehran
15 minutes discussion

3. Recent TAVI data – 15 minutes – Lars Sondergaard
15 minutes discussion

5.30 - 6.30pm: PART 3.2 - Live Cases - 60 minutes

1. Erasmus Medical Center, NL (Lean TAVI)

2. Erasmus Medical Center, NL (Physiology Guided MVD PCI)

6.30 - 7.50pm: PART 3.3 - Future Technologies and Controversies - 80 minutes

SESSION CHAIRS: Nicolas Van Mieghem, Ajay Kirtane
SESSION PANEL: Holger Thiele, Didier Tchetche, David Hildick-Smith, Roxana Mehran
1. MCS in HRPCI – Changing perspectives? – 15 minutes – Holger Thiele
15 minutes discussion

2. Embolic protection in TAVI – 15 minutes – David Hildick-Smith
10 minutes discussion

3. Non-hyperemic angio-, OCT-, MSCT derived coronary physiology – 15 minutes – Joost Daemen
10 minutes discussion

7.50pm: Wrap up of Day 3

Led by Nicolas Van Mieghem - 10 minutes

Learning Objectives

Following the activities, the participants will be able to:

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession

Target Audience

  • Cardiologists, interventionalists and surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease.

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Dr Nicolas M Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology at the Thoraxcenter, Erasmus Medical Center, as a senior staff member in February 2010. 

He is involved in the percutaneous coronary interventions and structural heart program. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored approximately 130 scientific papers in peer-reviewed journals. 

Dr Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and is currently Medical Director of the department of Interventional cardiology at the Thoraxcenter.

View full profile
Kendra J Grubb

Kendra J Grubb

View full profile
David Hildick-Smith

David Hildick-Smith

David Hildick-Smith is a Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and has more than 15 years experience of Interventional Cardiology.

View full profile
Holger Thiele

Holger Thiele

Dr Holger Thiele, former director and full professor in the Department of Internal Medicine/Cardiology/Angiology of the University Heart Center Lübeck at the University of Lübeck has been nominated by the faculty of the University of Leipzig as full Professor and Director of the Department of Internal Medicine/Cardiology of the Heart Center Leipzig which is affiliated with the University of Leipzig. 

View full profile